1. Home
  2. ZLAB vs CXT Comparison

ZLAB vs CXT Comparison

Compare ZLAB & CXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • CXT
  • Stock Information
  • Founded
  • ZLAB 2013
  • CXT 1855
  • Country
  • ZLAB China
  • CXT United States
  • Employees
  • ZLAB N/A
  • CXT N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • CXT Office Equipment/Supplies/Services
  • Sector
  • ZLAB Health Care
  • CXT Industrials
  • Exchange
  • ZLAB Nasdaq
  • CXT Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • CXT 3.2B
  • IPO Year
  • ZLAB 2017
  • CXT N/A
  • Fundamental
  • Price
  • ZLAB $35.17
  • CXT $55.57
  • Analyst Decision
  • ZLAB Buy
  • CXT Buy
  • Analyst Count
  • ZLAB 5
  • CXT 4
  • Target Price
  • ZLAB $54.28
  • CXT $77.00
  • AVG Volume (30 Days)
  • ZLAB 987.9K
  • CXT 546.5K
  • Earning Date
  • ZLAB 08-05-2025
  • CXT 08-06-2025
  • Dividend Yield
  • ZLAB N/A
  • CXT 1.26%
  • EPS Growth
  • ZLAB N/A
  • CXT N/A
  • EPS
  • ZLAB N/A
  • CXT 2.91
  • Revenue
  • ZLAB $418,326,000.00
  • CXT $1,503,500,000.00
  • Revenue This Year
  • ZLAB $44.07
  • CXT $8.08
  • Revenue Next Year
  • ZLAB $49.13
  • CXT $8.53
  • P/E Ratio
  • ZLAB N/A
  • CXT $18.53
  • Revenue Growth
  • ZLAB 43.72
  • CXT 9.28
  • 52 Week Low
  • ZLAB $16.01
  • CXT $41.54
  • 52 Week High
  • ZLAB $44.34
  • CXT $67.01
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 48.52
  • CXT 49.00
  • Support Level
  • ZLAB $34.55
  • CXT $52.95
  • Resistance Level
  • ZLAB $36.73
  • CXT $56.06
  • Average True Range (ATR)
  • ZLAB 1.35
  • CXT 1.40
  • MACD
  • ZLAB -0.61
  • CXT -0.31
  • Stochastic Oscillator
  • ZLAB 7.35
  • CXT 19.78

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About CXT Crane NXT Co.

Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.

Share on Social Networks: